Simply Good Foods reported fiscal second‑quarter 2026 revenue of $326.0 million, a 9.4% decline from the $359.7 million earned in the same period last year. The company’s adjusted earnings per share rose to $0.45, beating the consensus estimate of $0.40 by $0.05, or 12.5%. The earnings beat was largely driven by disciplined cost management that offset the revenue shortfall, while the revenue miss reflected a broader weakness in the nutritional‑snack market and a loss of market share in legacy brands.
Quest, the company’s high‑margin protein‑bar line, grew 0.3% in sales, a modest increase that helped cushion the overall decline. In contrast, Atkins sales fell 26.6% and OWYN sales dropped 16.8%, driven by distribution challenges for Atkins and a product‑quality remediation program for OWYN that added cost and reduced volume. These segment results explain the mixed performance across the portfolio and highlight the need for a sharper focus on high‑margin brands.
Gross profit contracted 20.8% to $103.0 million, a 4.6‑percentage‑point drop in gross margin to 31.6%. The compression was caused by higher cocoa costs, tariff impacts, and the $249.0 million impairment charge on Atkins and OWYN intangible assets. The impairment, split into $62.0 million for Atkins and $187.0 million for OWYN, reflects lower projected future revenue for those brands and signals a strategic shift away from legacy products.
Management lowered full‑year 2026 sales guidance to $1.310 billion–$1.350 billion, down from the prior range of $1.422 billion–$1.480 billion. The cut reflects weaker retail takeaway demand and persistent cost pressures, and it signals a cautious outlook for the remainder of the year. The company reaffirmed its $150 million buyback program, borrowing $150 million and repurchasing 4.6 million shares for about $89 million during the quarter.
CEO Joe Scalzo said the company is “not satisfied with our current performance” and is focusing on three priorities: improving cost structure and margins, ensuring consistency in strategic choices, and rebuilding brand investment. Investors reacted negatively, citing the revenue miss and the guidance cut as the main drivers of the market’s response. The results underscore the company’s need to accelerate margin recovery and regain momentum in its high‑margin Quest line while addressing the challenges in Atkins and OWYN.
Overall, the earnings release highlights a company in transition. Revenue and margin contraction, coupled with a significant impairment charge, point to a near‑term struggle. However, the EPS beat and the company’s focus on cost discipline and brand investment suggest a potential for recovery if the high‑margin Quest segment can expand and the legacy brands can be successfully repositioned or divested. The guidance cut and the impairment charge will likely keep long‑term investors cautious until the company demonstrates sustained improvement in sales and profitability.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.